Duke University at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Duke University brings 12 presentations to SABCS 2026 in San Antonio. The Durham university presents on PI3K-pathway drug side effects, spatial profiling in triple-negative disease, locoregional therapy and supplemental MRI screening, and one of its faculty moderates a session.

OrganizationSABCS 2026 Attendance
Duke University
Durham, NC
Academic
A private research university with a medical school, hospital and cancer institute.
Session
Tue Dec 8
2:30–4:15pm
Talk
Wed Dec 9
7:42–7:45am
Poster
Wed Dec 9
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Identification of breast cancer-associated gene signatures predictive of pathological complete response
Exhibit Hall
Breast Cancer Risk, Genetics, and Prevention
Poster
Thu Dec 10
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Single-cell-informed deconvolution identifies a dormant malignant cell fraction associated with overall survival in ER+/HER2− breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Duke University

Tell us what you sell and we’ll find the people at Duke University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction